These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 26359880)
1. The role of ultrasonographic findings to predict molecular subtype, histologic grade, and hormone receptor status of breast cancer. Çelebi F; Pilancı KN; Ordu Ç; Ağacayak F; Alço G; İlgün S; Sarsenov D; Erdoğan Z; Özmen V Diagn Interv Radiol; 2015; 21(6):448-53. PubMed ID: 26359880 [TBL] [Abstract][Full Text] [Related]
2. Assessing the role of ultrasound in predicting the biological behavior of breast cancer. Irshad A; Leddy R; Pisano E; Baker N; Lewis M; Ackerman S; Campbell A AJR Am J Roentgenol; 2013 Feb; 200(2):284-90. PubMed ID: 23345347 [TBL] [Abstract][Full Text] [Related]
3. Correlation of sonographic features of invasive ductal mammary carcinoma with age, tumor grade, and hormone-receptor status. Aho M; Irshad A; Ackerman SJ; Lewis M; Leddy R; Pope TL; Campbell AS; Cluver A; Wolf BJ; Cunningham JE J Clin Ultrasound; 2013 Jan; 41(1):10-7. PubMed ID: 22996916 [TBL] [Abstract][Full Text] [Related]
4. Identification of a correlation between the sonographic appearance and molecular subtype of invasive breast cancer: A review of 311 cases. Wu T; Li J; Wang D; Leng X; Zhang L; Li Z; Jing H; Kang J; Tian J Clin Imaging; 2019; 53():179-185. PubMed ID: 30415183 [TBL] [Abstract][Full Text] [Related]
5. The biology of malignant breast tumors has an impact on the presentation in ultrasound: an analysis of 315 cases. Wojcinski S; Stefanidou N; Hillemanns P; Degenhardt F BMC Womens Health; 2013 Nov; 13():47. PubMed ID: 24252758 [TBL] [Abstract][Full Text] [Related]
6. Histological Grade and Immunohistochemical Biomarkers of Breast Cancer: Correlation to Ultrasound Features. Au FW; Ghai S; Lu FI; Moshonov H; Crystal P J Ultrasound Med; 2017 Sep; 36(9):1883-1894. PubMed ID: 28556296 [TBL] [Abstract][Full Text] [Related]
7. BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer. Candelaria RP; Spak DA; Rauch GM; Huo L; Bassett RL; Santiago L; Scoggins ME; Guirguis MS; Patel MM; Whitman GJ; Moulder SL; Thompson AM; Ravenberg EE; White JB; Abuhadra NK; Valero V; Litton J; Adrada BE; Yang WT Acad Radiol; 2022 Jan; 29 Suppl 1(Suppl 1):S35-S41. PubMed ID: 34272161 [TBL] [Abstract][Full Text] [Related]
8. Mammography and ultrasound features of triple-negative breast cancer. Kojima Y; Tsunoda H Breast Cancer; 2011 Jul; 18(3):146-51. PubMed ID: 20972742 [TBL] [Abstract][Full Text] [Related]
9. Ultrasonographic features of triple-negative breast cancer: a comparison with other breast cancer subtypes. Yang Q; Liu HY; Liu D; Song YQ Asian Pac J Cancer Prev; 2015; 16(8):3229-32. PubMed ID: 25921124 [TBL] [Abstract][Full Text] [Related]
10. Triple-negative breast cancers: associations between imaging and pathological findings for triple-negative tumors compared with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancers. Boisserie-Lacroix M; Macgrogan G; Debled M; Ferron S; Asad-Syed M; McKelvie-Sebileau P; Mathoulin-Pélissier S; Brouste V; Hurtevent-Labrot G Oncologist; 2013; 18(7):802-11. PubMed ID: 23821326 [TBL] [Abstract][Full Text] [Related]
11. Descriptive analysis of molecular subtypes in Tunisian breast cancer. Fourati A; Boussen H; El May MV; Goucha A; Dabbabi B; Gamoudi A; Sfar R; Rahal K; El May A; Ben Abdallah M Asia Pac J Clin Oncol; 2014 Jun; 10(2):e69-74. PubMed ID: 23176549 [TBL] [Abstract][Full Text] [Related]
12. Correlation between imaging features and molecular subtypes of breast cancer in young women (≤30 years old). Huang J; Lin Q; Cui C; Fei J; Su X; Li L; Ma J; Zhang M Jpn J Radiol; 2020 Nov; 38(11):1062-1074. PubMed ID: 32562180 [TBL] [Abstract][Full Text] [Related]
13. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228 [TBL] [Abstract][Full Text] [Related]
14. Breast ultrasonographic and histopathological characteristics without any mammographic abnormalities. Tamaki K; Ishida T; Miyashita M; Amari M; Ohuchi N; Kamada Y; Uehara K; Tamaki N; Sasano H Jpn J Clin Oncol; 2012 Mar; 42(3):168-74. PubMed ID: 22217577 [TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China. Zhu X; Ying J; Wang F; Wang J; Yang H Breast Cancer Res Treat; 2014 Oct; 147(3):551-5. PubMed ID: 25234844 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and Ultrasonic Features of Triple-Negative Breast Cancers: A Comparison with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Breast Cancers. Wang D; Zhu K; Tian J; Li Z; Du G; Guo Q; Wu T; Li J Ultrasound Med Biol; 2018 May; 44(5):1124-1132. PubMed ID: 29482888 [TBL] [Abstract][Full Text] [Related]
17. Mammographic and ultrasonographic features of triple-negative breast cancer: a comparison with other breast cancer subtypes. Kim MY; Choi N Acta Radiol; 2013 Oct; 54(8):889-94. PubMed ID: 23761558 [TBL] [Abstract][Full Text] [Related]
18. Breast cancer in very young women (<30 years): Correlation of imaging features with clinicopathological features and immunohistochemical subtypes. An YY; Kim SH; Kang BJ; Park CS; Jung NY; Kim JY Eur J Radiol; 2015 Oct; 84(10):1894-902. PubMed ID: 26198117 [TBL] [Abstract][Full Text] [Related]
19. Sonographic features of triple-negative and non-triple-negative breast cancer. Wojcinski S; Soliman AA; Schmidt J; Makowski L; Degenhardt F; Hillemanns P J Ultrasound Med; 2012 Oct; 31(10):1531-41. PubMed ID: 23011616 [TBL] [Abstract][Full Text] [Related]
20. Luminal subtypes predict improved survival following central nervous system metastasis in patients with surgically managed metastatic breast carcinoma. Wiens AL; Martin SE; Bertsch EC; Vance GH; Stohler RA; Cheng L; Badve S; Hattab EM Arch Pathol Lab Med; 2014 Feb; 138(2):175-81. PubMed ID: 24476516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]